🇺🇸 FDA
Company

Foghorn

Foghorn Therapeutics

FHTX pharma USA

Quick answer

Foghorn is a pharma company (FHTX) headquartered in CAMBRIDGE, MA, USA with 5 tracked pipeline programs.

Pipeline (5)

project

FHD-286

Small Cell Lung Cancer

Phase 2 · small_molecule · active

1 trials project

Decitabine

Acute Myeloid Leukemia

Phase 1 · small_molecule · active

1 trials project

FHD-286

Advanced Hematologic Malignancy

Phase 1 · small_molecule · active

1 trials project

FHD-286

Metastatic Uveal Melanoma

Phase 1 · small_molecule · terminated

1 trials project

FHD-609

Advanced Synovial Sarcoma

Phase 1 · small_molecule · terminated

1 trials

Patents (8)

patent

US 12391686

Compounds and uses thereof

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12384776

Compounds and uses thereof

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12383555

Methods of treating cancers

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12383560

Compounds and uses thereof

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12351579

Compounds and uses thereof

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12139487

Compounds and uses thereof

Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11851445

Compounds and uses thereof

Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11787800

BRD9 degraders and uses thereof

Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)